REVB Revelation Biosciences Corp: Net earnings per share for the last 12 months

Public company logo of Revelation Bio (REVB)

Risks of clinical trial failure and pressure from major players create high uncertainty for Revelation Biosciences (REVB). A year-over-year (TTM) EPS comparison visualizes the valuation dynamics, where the 95.30 level reflects the current profit magnitude. Revelation Biosciences (REVB) focuses on respiratory infection protection for high-risk groups. The startup's fate depends on the success of drugs targeting postoperative inflammation, regardless of macroeconomic conditions.

REVB Revelation Biosciences Inc Earnings per share for the last twelve months (02/11/2024 - 11/17/2026)

REVB (Revelation Biosciences): analytical breakdowns and indicator data

- market value and analyst target forecast:
Fundamental company valuation:REVB, Revelation Bio
Core merchandise of Revelation Biosciences Corp

Revelation Biosciences occupies a high-tech biopharmaceutical niche, focusing on immunomodulators for the therapy of respiratory pathologies. The year-over-year earnings per share dynamics reflect actual capital management efficiency and operational resilience. An analysis of the EPS YoY TTM growth rate allows for an assessment of net income change relative to the previous year. For a company at the clinical trial stage, this indicator signals the ability to fund the scaling of development. A positive trend would confirm the market value of future data publications from mid-phase tests.

Direct competitors

argenx N.V. (ARGX) - Net earnings per share for the last 12 months|BioNTech Pharma (BNTX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Abivax|Net earnings per share for the last 12 months ADMA|Net earnings per share (EPS TTM) protagonist-inc.com|Earnings per share for the last twelve months Immunovant Corp (IMVT)|Kiniksa - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) GRFS (grifols.com)|Adaptive Biotechnologies Corp (ADPT) - Net earnings per one share for the last twelve months|celldex.com - Net earnings per share (EPS TTM)|AUPH - Net earnings per share (EPS TTM)|BCRX: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Vera Therapeutics Inc (VERA)|DNTH (Dianthus Therapeutics Inc) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Pharvaris Pharma|Net earnings per share (EPS TTM) ABCL|TRML (tourmalinebio.com) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) PGEN (Precigen Inc)|PHAR - Net earnings per share for the last 12 months|NKTR - Earnings per share for the last twelve months|UPB - Net earnings per share (EPS TTM)|ZBIO: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Immunome, Inc.|Earnings per share for the last twelve months Gossamer Bio|Net earnings per share (EPS TTM) KalVista Pharmaceuticals Inc|Net earnings per share for the last 12 months SEPN (Septerna Corp)|PVLA (Pieris Pharmaceuticals Inc) - Earnings per share for the trailing year|Net earnings per share (EPS TTM) SVRA (savarapharma.com)|Earnings per share for the trailing year RIGL|ANAB: Net earnings per share for the last 12 months|Earnings per share for the trailing year ATXS (Astria Therapeutics, Inc.)|ENGN: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months RAPT Therapeutics, Inc. (RAPT)|Earnings per share for the last twelve months aerovatetx.com|Net earnings per share (EPS TTM) aclaristx.com|Earnings per share for the last twelve months Kyverna Therapeutics (KYTX)|Net earnings per share for the last four quarters Tiziana Life Sciences Ltd|Net earnings per share (EPS TTM) CABA (Cabaletta Bio Inc)|VTYX: Earnings per share for the last 12 months|Theratechnologies, Inc. - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Avalo Therapeutics, Inc AVTX|ELDN (Eledon Pharmaceuticals) - Net earnings per share for the last 12 months|Agenus Inc. - Earnings per share for the trailing year|Earnings per share for the last twelve months Climb Bio|Net earnings per share (EPS TTM) Zura Bio Ltd|Net earnings per share for the last 12 months ATYR (aTyr Pharma Inc)|Net earnings per share for the last four quarters Adagene Inc|Earnings per share for the last twelve months ImageneBio Inc IMA|Earnings per share for the last four quarters STTK (shattucklabs.com)|EQ: Net earnings per share for the last 12 months|CNTB: Earnings per share for the last twelve months|IMUX: Net earnings per share (EPS TTM)|Atara Biotherapeutics (ATRA) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months IFRX|Net earnings per share (EPS TTM) X4 Pharmaceuticals Inc.|Earnings per share for the last twelve months Adicet Bio Inc. (ACET)|Net earnings per share for the last 12 months Celularity CELU|Net earnings per share (EPS TTM) INMB (INmune Bio Corporation)|Net earnings per share for the last four quarters Barinthus Biotherapeutics (BRNS)|KZR - Earnings per share for the last twelve months|SABS - Net earnings per share (EPS TTM)|Akari Therapeutics, Plc (AKTX) - Earnings per share for the last twelve months|Enlivex Therapeutics, Ltd. (ENLV) - Net earnings per share (EPS TTM)|QTTB (Q32 Bio Inc) - Net earnings per share (EPS TTM)|geovax.com (GOVX) - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months EDSA (Edesa Biotech)|Net earnings per share for the last four quarters iBio Inc|Net earnings per share (EPS TTM) CARM (Carisma Therapeutics Inc)|Earnings per share for the trailing year XTLB|BOLT: Net earnings per share for the last 12 months|HCW Biologics (HCWB) - Net earnings per share for the last 12 months|Aptevo (APVO) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months AIM ImmunoTech|Net earnings per share for the last 12 months ADTX|GRI Bio Corporation (GRI) - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months XRTX (XORTX Therapeutics Inc.)|Vyome Holdings Inc - Earnings per share for the last 12 months|Earnings per share for the last twelve months Indaptus Therapeutics Inc INDP|Net earnings per share (EPS TTM) Scinai SCNI|CALI - Earnings per share for the last twelve months|Earnings per one share for the last 12 months AFMD|ALLK (Allakos Therapeutics) - Net earnings per share for the last 12 months|HOOKIPA - Earnings per share for the trailing year|IGMS (IGM Biosciences) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months iTeos Therapeutics Inc ITOS|Earnings per share for the last twelve months oceanbiomedical.com (OCEA)|Net earnings per share for the last 12 months TC Biopharm TCBP|Net earnings per share (EPS TTM) THRD (Third Harmonic Bio, Inc.)